Please login to the form below

Not currently logged in


This page shows the latest MRT5500 news and features for those working in and with pharma, biotech and healthcare.

Sanofi to invest €400m annually in mRNA vaccines facility

Sanofi to invest €400m annually in mRNA vaccines facility

Participants taking part in the phase 1/2 trial will receive either one dose of MRT5500 or two doses administered 21 days apart. ... The companies are also undertaking preclinical studies to evaluate if MRT5500 and additional mRNA vaccine candidates can

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Genetic Digital

Genetic Digital specialises in developing digital marketing solutions for the healthcare, medical and pharmaceutical sectors. From developing a digital strategy,...

Latest intelligence

Environment: where does the pharmaceutical industry stand?
The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...